JAC Advance Access published online on May 29, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg287
© 2003 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original article
1 Department of Molecular Microbiology and Immunology, Bloomberg
School of Public Health,
Johns Hopkins University, Baltimore, MD 21205, USA
* Corresponding author. E-mail: yzhang{at}jhsph.edu.
Received 21 January 2003
; revised 11 April 2003
; accepted 16 April 2003
The susceptibility of Mycobacterium tuberculosis and Mycobacterium smegmatis to a range of weak acids and
acid pH was investigated. M. tuberculosis was found
to be more susceptible to acid pH and weak acids than M.
smegmatis. The weak acids were more active against M.
tuberculosis at acid pH than at neutral pH. M.
tuberculosis was found to be less able to maintain its internal
pH and membrane potential at acid pH than M. smegmatis.
The antituberculous activity of weak acids correlated with their
ability to disrupt the membrane potential but not the internal pH.
The significance of these findings is discussed in relation to
M. tuberculosis physiology and development
of new antituberculous agents.
Keywords: weak acid, antimicrobial susceptibility, pH
homeostasis, membrane potential, Mycobacterium tuberculosis
Susceptibility of Mycobacterium tuberculosis to
weak acids
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Gu, L. Constantino, and Y. Zhang Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamide J. Med. Microbiol., September 1, 2008; 57(9): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. S. Rao, S. Alonso, L. Rand, T. Dick, and K. Pethe The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis PNAS, August 19, 2008; 105(33): 11945 - 11950. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, D. E. Anderson, M. Rajagopalan, and H. P. Erickson Assembly Dynamics of Mycobacterium tuberculosis FtsZ J. Biol. Chem., September 21, 2007; 282(38): 27736 - 27743. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li and Y. Zhang PhoU Is a Persistence Switch Involved in Persister Formation and Tolerance to Multiple Antibiotics and Stresses in Escherichia coli Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2092 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Singh, C. Wesley, G. P. S. Jadaun, S. K. Malonia, R. Das, P. Upadhyay, J. Faujdar, P. Sharma, P. Gupta, A. K. Mishra, et al. Comparative Evaluation of Lowenstein-Jensen Proportion Method, BacT/ALERT 3D System, and Enzymatic Pyrazinamidase Assay for Pyrazinamide Susceptibility Testing of Mycobacterium tuberculosis J. Clin. Microbiol., January 1, 2007; 45(1): 76 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Wade and Y. Zhang Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro J. Antimicrob. Chemother., November 1, 2006; 58(5): 936 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. M. Wade, A. Scorpio, H. Zhang, and Z. Sun Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid J. Antimicrob. Chemother., November 1, 2003; 52(5): 790 - 795. [Abstract] [Full Text] [PDF] |
||||





